Pineapple Express(PNPL)
USD --+0.00%
Reward39Moderate
Risk93High
📊75%Data
Strong 241% profit margin · Revenue growing 31649% YoY
PNPL
+0.0 · +0.00%
USD · PINK
Pineapple Express | Healthcare
Capital Destroyer
Market Cap:5.62M
ℹ️
Reward Rating
39
Moderate
Bottom 5% (model universe)
75% data coverage
ℹ️
Risk Rating
93
High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on PNPL to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Pineapple Express?

operates as a portfolio management company in the cannabis sector in the United States.

PNPL · Verdict

Limited reward · high risk

PNPL has limited near-term tailwinds — volatility and balance sheet weigh on the model output.

Based on 88% data coverage

PNPL · Verdict

What’s working & what to watch

Watchouts 5

  • Volatility5/100

    Weak vs peers

  • Balance sheet6/100

    Current ratio 0.10

  • Cash flow6/100

    -28% free-cash-flow margin

  • Profitability9/100

    -335% net margin · -342% ROE

  • Growth41/100

    Earnings +8.4% CAGR

Model-based scoring. For information only — not financial advice.

What is Pineapple Express?

operates as a portfolio management company in the cannabis sector in the United States. The company procures and leases properties to licensed cannabis operators; and provides hemp-derived CBD sales via online and in-store transactions. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 5.62M.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Elevated volatility implies higher downside and expectation risk.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (39)

The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are high — this profile reflects meaningful downside exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap5.62M
P/E RatioN/A
Dividend YieldN/A
52 Week High0.2
52 Week Low0.0629
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding73M
No. of EmployeesN/A
IndustryPharmaceutical Retailers
ExchangePINK
Beta40.689
CurrencyUSD